Oral Adverse Effect

Medication-Induced Xerostomia

Oral aspects of therapy with: Multiple classes: anticholinergics, antidepressants (TCAs, SSRIs), antihistamines, diuretics, opioids

Evidence: High Iuliana Ferbei, PharmacistUpdated: July 12, 2026

This content is intended solely as professional information for healthcare professionals. It does not replace individual advice or treatment decisions. Any change to or discontinuation of medication should only be made on the instruction of the treating physician.

At a glance

  • Xerostomia is one of the most common oral adverse drug effects, particularly with polypharmacy in older patients
  • The risk can be additive: the overall xerogenic medication burden matters, with anticholinergic burden being an important contributor
  • Reduced salivary flow alters the biofilm and pH and markedly increases caries risk
  • Taking a medication history in the dental practice and counseling in the pharmacy are central levers for prevention
  • Changes to therapy are decisions for the prescribing physician alone

Oral Manifestations

💧 Dry mouth
🦷 Root caries risk
👅 Dysgeusia
🔥 Burning mouth sensation
🍄 Candidiasis risk
😬 Denture problems

Medication-induced xerostomia refers to dry mouth resulting from reduced or altered salivary secretion caused by pharmacological agents. It is among the most common oral adverse drug effects, particularly in older patients on multiple medications. A clinical distinction is useful here: xerostomia describes the subjective sensation of dryness, while hyposalivation describes an objectively measurable reduction in salivary flow. The two frequently occur together, but not always.

  • Subjective dry mouth and hyposalivation
  • Increased caries risk, particularly root caries
  • Changes in the oral biofilm and in pH
  • Mucosal discomfort, burning mouth sensation, taste alterations
  • Difficulties with denture retention, and halitosis

Mechanism

The central mechanisms are anticholinergic blockade of muscarinic receptors in the salivary glands, sympathomimetic effects, and changes in salivary composition. The effect is frequently dose-dependent and additive: the overall risk can increase as additional xerogenic medications are added. Anticholinergic burden is an important component of this cumulative medication burden, particularly when several drugs with anticholinergic properties are used concurrently.

Clinical Relevance

For dentists: a medication history should be standard practice when caries activity increases without a clear explanation, or when mucosal complaints or denture intolerance are present. Shorter recall intervals are advisable for patients on xerogenic medication.

For prophylaxis teams and dental hygienists: integrate xerostomia screening into history taking, and adapt fluoride and remineralization protocols to the elevated risk.

For pharmacists: when dispensing long-term xerogenic medication, proactively address oral health. Medication review in patients with polypharmacy can provide an important opportunity for prevention.

Patient Counseling

  • Watch for symptoms: persistent dry mouth, a sticky feeling, difficulty swallowing, increased caries activity
  • Speak with a physician or pharmacist if symptoms are new or troublesome
  • General measures: drink water regularly, use sugar-free chewing gum, maintain careful oral hygiene, and attend regular dental check-ups

Important: never stop or alter medication independently. Any change to or discontinuation of medication should only be made on the instruction of the treating physician.

Selected Substances

Substance Class Frequency Evidence
Amitriptyline
German trade name examples: Saroten, Amineurin; generics available		 Tricyclic antidepressants (TCAs) Very common (≥ 1/10) High
Sertraline
German trade name example: Zoloft; generics widely available		 Selective serotonin reuptake inhibitors (SSRIs) Common (≥ 1/100 to < 1/10) High
Solifenacin
German trade name example: Vesikur; generics widely available		 Anticholinergics (urological agents) Very common (≥ 1/10) High

Sources

Wolff A. et al.: A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea. Drugs R D, 2017.

Villa A. et al.: Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag, 2015.

Summaries of Product Characteristics (SmPC) for the substances named, current versions.

Frequently Asked Questions

Which medications most commonly cause dry mouth?

The drug classes most frequently involved include anticholinergics, tricyclic antidepressants, SSRIs, antihistamines, diuretics, opioids, and certain antihypertensives. The risk rises markedly with the number of medications taken concurrently.

Why does dry mouth increase caries risk?

Saliva buffers acids, supports remineralization of the enamel, and clears food residues and bacteria. When salivary flow is reduced, the oral ecosystem shifts: pH drops more frequently and for longer, the biofilm changes, and the risk of caries, particularly root caries, increases markedly.

Should a medication be discontinued because of dry mouth?

No. Medication must never be discontinued or have its dose changed independently. Where dry mouth is troublesome, the appropriate step is a conversation with the treating physician or a pharmacist. In many cases, symptoms can be alleviated through targeted oral-care and behavioral measures.

Related Lexicon terms:BiofilmpHRemineralizationSalivaXerostomia
← Back to the Professional Hub

Disclaimer: This page provides professional information but does not replace individual medical or pharmaceutical advice. Any change to medication should only be made on the instruction of the treating physician.